Select Page

Company to buy

  • Size: Small scale pharma company
  • Revenue: 1-5M EUR
  • Investment amount: <5M EUR
  • Location of the target company: EU
  • Reason for acquisition: The buyer is interested in prolonging its value chain for B2B business in international markets, like Brazil, China and the EU while producing and marketing in Europe. The target would also be useful in distribution of injectable drugs across the EU and expanding the portfolio of EU-manufactured for marketing in China
  • #CFIE PHB060

Overview of this Buyer of innovative pharmaceutical companies in Europe

The Buyer has specialized in pharmaceutical distribution of Active Pharmaceutical Ingredients (API), Finished Dosage Forms (FDF) and services since 1989, with dedicated teams in Brazil, China, Germany, India and Malta.

Profile (strategy) of this Buyer of innovative pharmaceutical companies in Europe

The Buyer has made investments and joint ventures with other innovative pharmaceutical firms in the EU, Brazil and China with the aim of improving patient access to generic and innovative medicine.

The key focus is on novel delivery systems and the provision of EU-registered and manufactured drugs. Quality is also a priority, as evidenced by the EMA, FDA and ANVISA standards for APIs and FDFs held by its products.

Subscribe as an interested seller
Contact us to get details about this buyer of innovative pharmaceutical companies in europe

Activities and products of an ideal target pharma unit

This Buyer is looking for an acquisition of a small, generics manufacturer in the EU as well as investment opportunities into second and later stage health services and medicine technology. These assets are best described as healthcare products, branded prescription medicine and innovative drug delivery technology.

An innovation DNA is highly desirable, from product to delivery mechanism or online marketing.

Highlights of the Buyer of innovative pharmaceutical companies in Europe

  • The buyer is part of a family office-backed EU pharmaceutical group, with footprint a in Latin America, and China and distribution activities in Africa as well.
  • Established in 1989, the Buyer was merged into a century-old generic drug group and started expansion into Brazil and China
  • Products include OTC food supplements as well

More information on this buyer of innovative pharmaceutical companies in Europe

Please get in touch if you are interested in learning more about this buyer of innovative pharmaceutical companies in Europe. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as a seller for this Pharma buyer

en_GBEnglish (UK)